OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A roadmap for translational cancer glycoimmunology at single cell resolution
Andreia Peixoto, Andréia Miranda, Lúcio Lara Santos, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 8
Andreia Peixoto, Andréia Miranda, Lúcio Lara Santos, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Targeting galectin-driven regulatory circuits in cancer and fibrosis
Karina V. Mariño, Alejandro J. Cagnoni, Diego O. Croci, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 4, pp. 295-316
Open Access | Times Cited: 138
Karina V. Mariño, Alejandro J. Cagnoni, Diego O. Croci, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 4, pp. 295-316
Open Access | Times Cited: 138
Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors
Yasuyuki Matsumoto, Tongzhong Ju
Cancers (2023) Vol. 15, Iss. 14, pp. 3536-3536
Open Access | Times Cited: 21
Yasuyuki Matsumoto, Tongzhong Ju
Cancers (2023) Vol. 15, Iss. 14, pp. 3536-3536
Open Access | Times Cited: 21
Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines
Rui Freitas, Andreia Peixoto, Eduardo Ferreira, et al.
Biotechnology Advances (2023) Vol. 65, pp. 108144-108144
Open Access | Times Cited: 17
Rui Freitas, Andreia Peixoto, Eduardo Ferreira, et al.
Biotechnology Advances (2023) Vol. 65, pp. 108144-108144
Open Access | Times Cited: 17
A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy
Rui Freitas, Andréia Miranda, Dylan Ferreira, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 540-556
Closed Access | Times Cited: 5
Rui Freitas, Andréia Miranda, Dylan Ferreira, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 540-556
Closed Access | Times Cited: 5
Multilevel Plasticity and Altered Glycosylation Drive Aggressiveness in Hypoxic and Glucose-Deprived Bladder Cancer Cells
Andreia Peixoto, Dylan Ferreira, Andréia Miranda, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111758-111758
Open Access
Andreia Peixoto, Dylan Ferreira, Andréia Miranda, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111758-111758
Open Access
Glycan-based therapeutic approaches for bladder cancer: Overcoming clinical barriers
Rui Freitas, Andreia Peixoto, Lúcio Lara Santos, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189327-189327
Closed Access
Rui Freitas, Andreia Peixoto, Lúcio Lara Santos, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189327-189327
Closed Access
Glycan diversity in ovarian cancer: Unraveling the immune interplay and therapeutic prospects
Gerrit Wolters‐Eisfeld, Leticia Oliveira‐Ferrer
Seminars in Immunopathology (2024) Vol. 46, Iss. 6
Open Access | Times Cited: 1
Gerrit Wolters‐Eisfeld, Leticia Oliveira‐Ferrer
Seminars in Immunopathology (2024) Vol. 46, Iss. 6
Open Access | Times Cited: 1
Multilevel Plasticity and Altered Glycosylation Drive Aggressiveness in Hypoxic and Glucose-Deprived Bladder Cancer Cells
Andreia Peixoto, Dylan Ferreira, Andréia Miranda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Andreia Peixoto, Dylan Ferreira, Andréia Miranda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
